Adderall and Paranasal sinus hypersecretion - a phase IV clinical study of FDA data

Summary:

Paranasal sinus hypersecretion is found among people who take Adderall, especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years.

The phase IV clinical study analyzes which people take Adderall and have Paranasal sinus hypersecretion. It is created by eHealthMe based on reports of 42,811 people who have side effects when taking Adderall from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 04, 2022

42,811 people reported to have side effects when taking Adderall.
Among them, 17 people (0.04%) have Paranasal sinus hypersecretion.


What is Adderall?

Adderall has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 55,326 Adderall users for its effectiveness, alternative drugs and more.

What is Paranasal sinus hypersecretion?

Paranasal sinus hypersecretion is found to be associated with 704 drugs and 386 conditions by eHealthMe.

Number of Adderall and Paranasal sinus hypersecretion reports submitted per year:

Could Adderall cause Paranasal sinus hypersecretion?

Time on Adderall when people have Paranasal sinus hypersecretion *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 100 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Paranasal sinus hypersecretion when taking Adderall *:

  • female: 70.59 %
  • male: 29.41 %

Age of people who have Paranasal sinus hypersecretion when taking Adderall *:

  • 0-1: 0.0 %
  • 2-9: 7.69 %
  • 10-19: 7.69 %
  • 20-29: 7.69 %
  • 30-39: 23.08 %
  • 40-49: 15.38 %
  • 50-59: 15.38 %
  • 60+: 23.08 %

Common drugs people take besides Adderall *:

  1. Xyrem: 7 people, 41.18%
  2. Prednisone: 3 people, 17.65%
  3. Ambien: 3 people, 17.65%
  4. Epipen: 2 people, 11.76%
  5. Perforomist: 2 people, 11.76%
  6. Orencia: 2 people, 11.76%
  7. Norco: 2 people, 11.76%
  8. Nifedipine: 2 people, 11.76%
  9. Mucinex: 2 people, 11.76%
  10. Lexapro: 2 people, 11.76%

Common side effects people have besides Paranasal sinus hypersecretion *:

  1. Fatigue (feeling of tiredness): 7 people, 41.18%
  2. Nausea (feeling of having an urge to vomit): 5 people, 29.41%
  3. Nausea And Vomiting: 5 people, 29.41%
  4. Cough: 4 people, 23.53%
  5. Drowsiness: 4 people, 23.53%
  6. High Blood Pressure: 4 people, 23.53%
  7. Diarrhea: 4 people, 23.53%
  8. Feeling Abnormal: 3 people, 17.65%
  9. Stress And Anxiety: 3 people, 17.65%
  10. Pneumonia: 3 people, 17.65%

Common conditions people have *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.76%
  2. Bipolar Disorder (mood disorder): 2 people, 11.76%
  3. Cystic Fibrosis (disease of the secretary glands): 2 people, 11.76%
  4. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 5.88%
  5. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 5.88%
  6. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 5.88%
  7. Drowsiness: 1 person, 5.88%
  8. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.88%
  9. Hepatic Cancer Stage Iv: 1 person, 5.88%
  10. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Adderall and have Paranasal sinus hypersecretion?

Check whether Paranasal sinus hypersecretion is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Paranasal sinus hypersecretion and when was it recovered:

Expand to all the drugs that have ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate:

Alternative drugs to, pros and cons of Adderall:

Common Adderall side effects:

Browse all side effects of Adderall:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Paranasal sinus hypersecretion treatments and more:

COVID vaccines that are related to Paranasal sinus hypersecretion:

Common drugs associated with Paranasal sinus hypersecretion:

All the drugs that are associated with Paranasal sinus hypersecretion:

Common conditions associated with Paranasal sinus hypersecretion:

All the conditions that are associated with Paranasal sinus hypersecretion:

How the study uses the data?

The study uses data from the FDA. It is based on amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate (the active ingredients of Adderall) and Adderall (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: